Maternal Plasma DNA and RNA Sequencing for Prenatal Testing

Advances in Clinical Chemistry

Volumn 74, Issue , 2016, Pages 63-102

  Tamminga, Saskia ^a   van Maarle, Merel ^b   Henneman, Lidewij ^a   Oudejans, Cees B M ^a   Cornel, Martina C ^a   Sistermans, Erik A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

CfDNA testing; Fetal fraction; Massively parallel sequencing; NIPT; Noninvasive prenatal testing; Prenatal testing; RNA sequencing

Indexed keywords

BLOOD GROUP RHESUS SYSTEM; DNA; RHO(D) ANTIGEN; RNA;

ANEUPLOIDY; BLOOD; BLOOD GROUP RHESUS SYSTEM; DEVICES; ETHICS; FEMALE; FETUS; GENETIC SCREENING; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; INCIDENTAL FINDING; LABORATORY DIAGNOSIS; PRACTICE GUIDELINE; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM;

ANEUPLOIDY; DNA; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FETUS; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INCIDENTAL FINDINGS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PRENATAL DIAGNOSIS; RH-HR BLOOD-GROUP SYSTEM; RNA;

EID: 84955456410     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.acc.2015.12.004     Document Type: Chapter

References (148)

1. Lo Y.M., Chan K.C., Sun H., Chen E.Z., Jiang P., Lun F.M., Zheng Y.W., Leung T.Y., Lau T.K., Cantor C.R., Chiu R.W. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci. Transl. Med. 2010, 2:61-91.
2. Kitzman J.O., Snyder M.W., Ventura M., Lewis A.P., Qiu R., Simmons L.E., Gammill H.S., Rubens C.E., Santillan D.A., Murray J.C., Tabor H.K., Bamshad M.J., Eichler E.E., Shendure J. Noninvasive whole-genome sequencing of a human fetus. Sci. Transl. Med. 2012, 4:137-176.
3. Chitty L.S., Mason S., Barrett A.N., McKay F., Lench N., Daley R., Jenkins L.A. Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach. Prenat. Diagn. 2015, 35:656-662.
4. Daley R., Hill M., Chitty L.S. Non-invasive prenatal diagnosis: progress and potential. Arch. Dis. Child. Fetal Neonatal Ed. 2014, 99:F426-F430.
5. Weijerman M.E., de Winter J.P. Clinical practice. The care of children with Down syndrome. Eur. J. Pediatr. 2010, 169:1445-1452.
6. Lejeune J., Gautier M., Turpin R. Study of somatic chromosomes from 9 mongoloid children. C. R. Hebd. Seances Acad. Sci. 1959, 248:1721-1722.
7. Weijerman M.E., van Furth A.M., Vonk N.A., van Wouwe J.P., Broers C.J., Gemke R.J. Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study. J. Pediatr. 2008, 152:15-19.
8. Presson A.P., Partyka G., Jensen K.M., Devine O.J., Rasmussen S.A., McCabe L.L., McCabe E.R. Current estimate of Down Syndrome population prevalence in the United States. J. Pediatr. 2013, 163:1163-1168.
9. Loane M., Morris J.K., Addor M.C., Arriola L., Budd J., Doray B., Garne E., Gatt M., Haeusler M., Khoshnood B., Klungsoyr M.K., Latos-Bielenska A., McDonnell B., Mullaney C., O'Mahony M., Queisser-Wahrendorf A., Rankin J., Rissmann A., Rounding C., Salvador J., Tucker D., Wellesley D., Yevtushok L., Dolk H. Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. Eur. J. Hum. Genet. 2013, 21:27-33.
10. Hernandez D., Fisher E.M. Down syndrome genetics: unravelling a multifactorial disorder. Hum. Mol. Genet. 1996, 5(Spec. No):1411-1416.
11. Hyett J., Mogra R., Sonek J. First trimester ultrasound assessment for fetal aneuploidy. Clin. Obstet. Gynecol. 2014, 57:142-158.
12. Cole R., Jones G. Testing times: do new prenatal tests signal the end of Down syndrome?. N. Z. Med. J. 2013, 126:96-102.
13. Young C., von D.P., Alfirevic Z. Instruments for chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst. Rev. 2013, 1:CD000114.
14. Hahnemann J.M., Vejerslev L.O. European collaborative research on mosaicism in CVS (EUCROMIC)-fetal and extrafetal cell lineages in 192 gestations with CVS mosaicism involving single autosomal trisomy. Am. J. Med. Genet. 1997, 70:179-187.
15. Baffero G.M., Somigliana E., Crovetto F., Paffoni A., Persico N., Guerneri S., Lalatta F., Fogliani R., Fedele L. Confined placental mosaicism at chorionic villous sampling: risk factors and pregnancy outcome. Prenat. Diagn. 2012, 32:1102-1108.
16. Faas B.H., Cirigliano V., Bui T.H. Rapid methods for targeted prenatal diagnosis of common chromosome aneuploidies. Semin. Fetal Neonatal Med. 2011, 16:81-87.
17. Tabor A., Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn. Ther. 2010, 27:1-7.
18. Akolekar R., Beta J., Picciarelli G., Ogilvie C., D'Antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 2015, 45:16-26.
19. Evans M.I., Andriole S., Evans S.M. Genetics: update on prenatal screening and diagnosis. Obstet. Gynecol. Clin. North Am. 2015, 42:193-208.
20. Norwitz E.R., Levy B. Noninvasive prenatal testing: the future is now. Rev. Obstet. Gynecol. 2013, 6:48-62.
21. Benn P., Borrell A., Chiu R.W.K., Cuckle H., Dugoff L., Faas B., Gross S., Huang T., Johnson J., Maymon R., Norton M., Odibo A., Schielen P., Spencer K., Wright D., Yaron Y. Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat. Diagn. 2015, 35(8):725-734.
22. Lapaire O., Holzgreve W., Oosterwijk J.C., Brinkhaus R., Bianchi D.W. Georg Schmorl on trophoblasts in the maternal circulation. Placenta 2007, 28:1-5.
23. Mandel P., Metais P. Les acides nucleiques du plasma sanguin chez l'homme. C. R. Acad. Sci. Paris 1948, 142:241-243.
24. Walknowska J., Conte F.A., Grumbach M.M. Practical and theoretical implications of fetal-maternal lymphocyte transfer. Lancet 1969, 1:1119-1122.
25. Bianchi D.W., Zickwolf G.K., Weil G.J., Sylvester S., DeMaria M.A. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:705-708.
26. Lo Y.M.D., Corbetta N., Chamberlain P.F., Rai V., Sargent I.L., Redman C.W., Wainscoat J.S. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350:485-487.
27. Lo Y.M., Tein M.S., Lau T.K., Haines C.J., Leung T.N., Poon P.M., Wainscoat J.S., Johnson P.J., Chang A.M., Hjelm N.M. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet. 1998, 62:768-775.
28. Faas B.H., Beuling E.A., Christiaens G.C., von dem Borne A.E., van der Schoot C.E. Detection of fetal RHD-specific sequences in maternal plasma. Lancet 1998, 352:1196.
29. Chiu R.W., Chan K.C., Gao Y., Lau V.Y., Zheng W., Leung T.Y., Foo C.H., Xie B., Tsui N.B., Lun F.M., Zee B.C., Lau T.K., Cantor C.R., Lo Y.M. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:20458-20463.
30. Fan H.C., Blumenfeld Y.J., Chitkara U., Hudgins L., Quake S.R. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:16266-16271.
31. Chiu R.W.K., Akolekar R., Zheng Y.W.L., Leung T.Y., Sun H., Chan K.C.A., Lun F.M.F., Go A.T.J.I., Lau E.T., To W.W.K., Leung W.C., Tang R.Y.K., Au-Yeung S.K.C., Lam H., Kung Y.Y., Zhang X., van Vugt J.M.G., Minekawa R., Tang M.H.Y., Wang J., Oudejans C.B.M., Lau T.K., Nicolaides K.H., Lo Y.M.D. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011, 342:c7401.
32. Chen E.Z., Chiu R.W., Sun H., Akolekar R., Chan K.C., Leung T.Y., Jiang P., Zheng Y.W., Lun F.M., Chan L.Y., Jin Y., Go A.T., Lau E.T., To W.W., Leung W.C., Tang R.Y., Au-Yeung S.K., Lam H., Kung Y.Y., Zhang X., van Vugt J.M., Minekawa R., Tang M.H., Wang J., Oudejans C.B., Lau T.K., Nicolaides K.H., Lo Y.M. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011, 6:e21791.
33. Benn P., Borell A., Chiu R., Cuckle H., Dugoff L., Faas B., Gross S., Johnson J., Maymon R., Norton M., Odibo A., Schielen P., Spencer K., Huang T., Wright D., Yaron Y. Aneuploidy screening: a position statement from a Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat. Diagn. 2012, 33(7):622-629.
34. The Noninvasive Prenatal Screening Work Group of the American College of Medical Genetics and Genomics ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet. Med. 2013, 15:395-398.
35. Norton M.E., Jacobsson B., Swamy G.K., Laurent L.C., Ranzini A.C., Brar H., Tomlinson M.W., Pereira L., Spitz J.L., Hollemon D., Cuckle H., Musci T.J., Wapner R.J. Cell-free DNA analysis for noninvasive examination of trisomy. N. Engl. J. Med. 2015, 372:1589-1597.
36. Langlois S., Brock J.-A. Current status in non-invasive prenatal detection of Down Syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma. J. Obstet. Gynaecol. Can. 2013, 35:177-181.
37. Allyse M., Minear M.A., Berson E., Sridhar S., Rote M., Hung A., Chandrasekharan S. Non-invasive prenatal testing: a review of international implementation and challenges. Int. J. Womens Health 2015, 7:113-126.
38. Tjoa M.L., Cindrova-Davies T., Spasic-Boskovic O., Bianchi D.W., Burton G.J. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am. J. Pathol. 2006, 169:400-404.
39. Flori E., Doray B., Gautier E., Kohler M., Ernault P., Flori J., Costa J.M. Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report. Hum. Reprod. 2004, 19:723-724.
40. Taglauer E.S., Wilkins-Haug L., Bianchi D.W. Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease. Placenta 2014, 35(Suppl.):S64-S68.
41. Wright C.F., Burton H. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum. Reprod. Update 2009, 15:139-151.
42. Zhou Y., Zhu Z., Gao Y., Yuan Y., Guo Y., Zhou L., Liao K., Wang J., Du B., Hou Y., Chen Z., Chen F., Zhang H., Yu C., Zhao L., Lau T.K., Jiang F., Wang W. Effects of maternal and fetal characteristics on cell-free fetal DNA fraction in maternal plasma. Reprod. Sci. 2015, 22:1429-1435.
43. Wang E., Batey A., Struble C., Musci T., Song K., Oliphant A. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat. Diagn. 2013, 33:662-666.
44. Boon E.M., Faas B.H. Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies. Prenat. Diagn. 2013, 33:563-568.
45. Sehnert A.J., Rhees B., Comstock D., de Feo E., Heilek G., Burke J., Rava R.P. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin. Chem. 2011, 57:1042-1049.
46. Bianchi D.W., Chudova D., Sehnert A.J., Bhatt S., Murray K., Prosen T.L., Garber J.E., Wilkins-Haug L., Vora N.L., Warsof S., Goldberg J., Ziainia T., Halks-Miller M. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA 2015, 314:162-169.
47. Jiang F., Ren J., Chen F., Zhou Y., Xie J., Dan S., Su Y., Xie J., Yin B., Su W., Zhang H., Wang W., Chai X., Lin L., Guo H., Li Q., Li P., Yuan Y., Pan X., Li Y., Liu L., Chen H., Xuan Z., Chen S., Zhang C., Zhang H., Tian Z., Zhang Z., Jiang H., Zhao L., Zheng W., Li S., Li Y., Wang J., Wang J., Zhang X. Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies. BMC Med. Genomics 2012, 5:57.
48. Zhang H., Gao Y., Jiang F., Fu M., Yuan Y., Guo Y., Zhu Z., Lin M., Liu Q., Tian Z., Zhang H., Chen F., Lau T.K., Zhao L., Yi X., Yin Y., Wang W. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146958 pregnancies. Ultrasound Obstet. Gynecol. 2015, 45:530-538.
49. Juneau K., Bogard P.E., Huang S., Mohseni M., Wang E.T., Ryvkin P., Kingsley C., Struble C.A., Oliphant A., Zahn J.M. Microarray-based cell-free DNA analysis improves noninvasive prenatal testing. Fetal Diagn. Ther. 2014, 36:282-286.
50. Dar P., Curnow K.J., Gross S.J., Hall M.P., Stosic M., Demko Z., Zimmermann B., Hill M., Sigurjonsson S., Ryan A., Banjevic M., Kolacki P.L., Koch S.W., Strom C.M., Rabinowitz M., Benn P. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am. J. Obstet. Gynecol. 2014, 211:527.
51. Papageorgiou E.A., Koumbaris G., Kypri E., Hadjidaniel M., Patsalis P.C. The epigenome view: an effort towards non-invasive prenatal diagnosis. Genes (Basel) 2014, 5:310-329.
52. Palomaki G.E., Kloza E.M., Lambert-Messerlian G.M., Haddow J.E., Neveux L.M., Ehrich M., van den Boom D., Bombard A.T., Deciu C., Grody W.W., Nelson S.F., Canick J.A. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet. Med. 2011, 13:913-920.
53. Song Y., Huang S., Zhou X., Jiang Y., Qi Q., Bian X., Zhang J., Yan Y., Cram D.S., Liu J. Non-invasive prenatal testing for fetal aneuploidies in the first trimester of pregnancy. Ultrasound Obstet. Gynecol. 2015, 45:55-60.
54. WISECONDOR (WIthin-SamplE COpy Number aberration DetectOR): detect fetal trisomies and smaller CNV's in a maternal plasma sample using whole-genome data, 2015 (29-9-2015).
55. Chan K.C., Zhang J., Hui A.B., Wong N., Lau T.K., Leung T.N., Lo K.W., Huang D.W., Lo Y.M. Size distributions of maternal and fetal DNA in maternal plasma. Clin. Chem. 2004, 50:88-92.
56. Gil M.M., Quezada M.S., Revello R., Akolekar R., Nicolaides K.H. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet. Gynecol. 2015, 45:249-266.
57. Grati F.R., Bajaj K., Malvestiti F., Agrati C., Grimi B., Malvestiti B., Pompilii E., Maggi F., Gross S., Simoni G., Ferreira J.C. The type of feto-placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedure. Prenat. Diagn. 2015, 35:994-998.
58. Benn P., Cuckle H. Theoretical performance of non-invasive prenatal testing for chromosome imbalances using counting of cell-free DNA fragments in maternal plasma. Prenat. Diagn. 2014, 34:778-783.
59. Cuckle H., Benn P., Pergament E. Cell-free DNA screening for fetal aneuploidy as a clinical service. Clin. Biochem. 2015, 48:932-941.
60. Canick J.A., Palomaki G.E., Kloza E.M., Lambert-Messerlian G.M., Haddow J.E. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat. Diagn. 2013, 33:667-674.
61. Nygren A.O., Dean J., Jensen T.J., Kruse S., Kwong W., van den Boom D., Ehrich M. Quantification of fetal DNA by use of methylation-based DNA discrimination. Clin. Chem. 2010, 56:1627-1635.
62. Ashoor G., Syngelaki A., Poon L.C., Rezende J.C., Nicolaides K.H. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet. Gynecol. 2013, 41:26-32.
63. Haghiac M., Vora N.L., Basu S., Johnson K.L., Presley L., Bianchi D.W., Hauguel-de M.S. Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women. Obesity 2012, 20:2213-2219.
64. Srinivasan A., Bianchi D.W., Liao W., Sehnert A.J., Rava R.P. Maternal plasma DNA sequencing: effects of multiple gestation on aneuploidy detection and the relative cell-free fetal DNA (cff DNA) per fetus. Am. J. Obstet. Gynecol. 2013, 208:S31.
65. Canick J.A., Kloza E.M., Lambert-Messerlian G.M., Haddow J.E., Ehrich M., van den Boom D., Bombard A.T., Deciu C., Palomaki G.E. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat. Diagn. 2012, 32:730-734.
66. Gromminger S., Yagmur E., Erkan S., Nagy S., Schock U., Bonnet J., Smerdka P., Ehrich M., Wegner R.D., Hofmann W., Stumm M. Fetal aneuploidy detection by cell-free DNA sequencing for multiple pregnancies and quality issues with vanishing twins. J. Clin. Med. 2014, 3:679-692.
67. Rava R.P., Srinivasan A., Sehnert A.J., Bianchi D.W. Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X. Clin. Chem. 2014, 60:243-250.
68. Palomaki G.E., Kloza E.M., Lambert-Messerlian G.M., van den Boom D., Ehrich M., Deciu C., Bombard A.T., Haddow J.E. Circulating cell free DNA testing: are some test failures informative?. Prenat. Diagn. 2015, 35:289-293.
69. Ashoor G., Poon L., Syngelaki A., Mosimann B., Nicolaides K.H. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: effect of maternal and fetal factors. Fetal Diagn. Ther. 2012, 31:237-243.
70. Gerovassili A., Garner C., Nicolaides K.H., Thein S.L., Rees D.C. Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities?. Prenat. Diagn. 2007, 27:104-110.
71. Wataganara T., Metzenbauer M., Peter I., Johnson K.L., Bianchi D.W. Placental volume, as measured by 3-dimensional sonography and levels of maternal plasma cell-free fetal DNA. Am. J. Obstet. Gynecol. 2005, 193:496-500.
72. Beiter T., Fragasso A., Hudemann J., Niess A.M., Simon P. Short-term treadmill running as a model for studying cell-free DNA kinetics in vivo. Clin. Chem. 2011, 57:633-636.
73. Breitbach S., Tug S., Simon P. Circulating cell-free DNA: an up-coming molecular marker in exercise physiology. Sports Med. 2012, 42:565-586.
74. Schlutter J.M., Hatt L., Bach C., Kirkegaard I., Kolvraa S., Uldbjerg N. The cell-free fetal DNA fraction in maternal blood decreases after physical activity. Prenat. Diagn. 2014, 34:341-344.
75. Christiansen S.C., Vanky E., Klungland H., Stafne S.N., Morkved S., Salvesen K.A., Saether M., Carlsen S.M. The effect of exercise and metformin treatment on circulating free DNA in pregnancy. Placenta 2014, 35:989-993.
76. Pan P.D., Peter I., Lambert-Messerlian G.M., Canick J.A., Bianchi D.W., Johnson K.L. Cell-free fetal DNA levels in pregnancies conceived by IVF. Hum. Reprod. 2005, 20:3152-3156.
77. Lapaire O., Volgmann T., Huang D., Hahn S., Holzgreve W., Zhong X.Y. Maternal smoking: effect on circulating cell-free fetal and total DNA levels in maternal plasma from the second trimester. Obstet. Gynecol. 2007, 110:1358-1363.
78. Taylor T.H., Gitlin S.A., Patrick J.L., Crain J.L., Wilson J.M., Griffin D.K. The origin, mechanisms, incidence and clinical consequences of chromosomal mosaicism in humans. Hum. Reprod. Update 2014, 20:571-581.
79. Bianchi D.W., Platt L.D., Goldberg J.D., Abuhamad A.Z., Sehnert A.J., Rava R.P. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet. Gynecol. 2012, 119:890-901.
80. Alberry M., Maddocks D., Jones M., Abdel H.M., Abdel-Fattah S., Avent N., Soothill P.W. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat. Diagn. 2007, 27:415-418.
81. Guibert J., Benachi A., Grebille A.G., Ernault P., Zorn J.R., Costa J.M. Kinetics of SRY gene appearance in maternal serum: detection by real time PCR in early pregnancy after assisted reproductive technique. Hum. Reprod. 2003, 18:1733-1736.
82. Hahnemann J.M., Vejerslev L.O. Accuracy of cytogenetic findings on chorionic villus sampling (CVS)-diagnostic consequences of CVS mosaicism and non-mosaic discrepancy in centres contributing to EUCROMIC 1986-1992. Prenat. Diagn. 1997, 17:801-820.
83. Grati F.R. Chromosomal mosaicism in human feto-placental development: implications for prenatal diagnosis. J. Clin. Med. 2014, 3:809-837.
84. Eggermann T., Soellner L., Buiting K., Kotzot D. Mosaicism and uniparental disomy in prenatal diagnosis. Trends Mol. Med. 2015, 21:77-87.
85. Lau T.K., Cheung S.W., Lo P.S., Pursley A.N., Chan M.K., Jiang F., Zhang H., Wang W., Jong L.F., Yuen O.K., Chan H.Y., Chan W.S., Choy K.W. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center. Ultrasound Obstet. Gynecol. 2014, 43:254-264.
86. Robinson W.P., Penaherrera M.S., Jiang R., Avila L., Sloan J., McFadden D.E., Langlois S., vond Dadelszen P. Assessing the role of placental trisomy in preeclampsia and intrauterine growth restriction. Prenat. Diagn. 2010, 30:1-8.
87. Miura K., Yoshiura K., Miura S., Kondoh T., Harada N., Yamasaki K., Fujimoto Y., Yamasaki Y., Tanigawa T., Kitajima Y., Shimada T., Yoshida A., Nakayama D., Tagawa M., Yoshimura S., Wagstaff J., Jinno Y., Ishimaru T., Niikawa N., Masuzaki H. Clinical outcome of infants with confined placental mosaicism and intrauterine growth restriction of unknown cause. Am. J. Med. Genet. 2006, 140:1827-1833.
88. Gardner M.R.J., Sutherland G.R., Shaffer L.G. Chromosome Abnormalities and Genetic Counselling 2012, Oxford University Press, Oxford.
89. Kotzot D. Prenatal testing for uniparental disomy: indications and clinical relevance. Ultrasound Obstet. Gynecol. 2008, 31:100-105.
90. Wang Y., Chen Y., Tian F., Zhang J., Song Z., Wu Y., Han X., Hu W., Ma D., Cram D., Cheng W. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin. Chem. 2014, 60:251-259.
91. Yao H., Zhang L., Zhang H., Jiang F., Hu H., Chen F., Jiang H., Mu F., Zhao L., Liang Z., Wang W. Noninvasive prenatal genetic testing for fetal aneuploidy detects maternal trisomy X. Prenat. Diagn. 2012, 32:1114-1116.
92. Song Y., Liu C., Qi H., Zhang Y., Bian X., Liu J. Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population. Prenat. Diagn. 2013, 33:700-706.
93. Lau T.K., Jiang F.M., Stevenson R.J., Lo T.K., Chan L.W., Chan M.K., Lo P.S., Wang W., Zhang H.Y., Chen F., Choy K.W. Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service. Prenat. Diagn. 2013, 33:602-608.
94. Snyder M.W., Simmons L.E., Kitzman J.O., Coe B.P., Henson J.M., Daza R.M., Eichler E.E., Shendure J., Gammill H.S. Copy-number variation and false positive prenatal aneuploidy screening results. N. Engl. J. Med. 2015, 372:1639-1645.
95. Straver R., Sistermans E.A., Holstege H., Visser A., Oudejans C.B., Reinders M.J. WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme. Nucleic Acids Res. 2014, 42:31.
96. Bayindir B., Dehaspe L., Brison N., Brady P., Ardui S., Kammoun M., Van der Veken L., Lichtenbelt K., Van Den Bogaert K., Van Houdt J., Peeters H., Van E.H., de Rave T., Legius E., Devriendt K., Vermeesch J.R. Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management. Eur. J. Hum. Genet. 2015, 23:1286-1293.
97. Pavlidis N.A. Coexistence of pregnancy and malignancy. Oncologist 2002, 7:279-287.
98. Osborne C.M., Hardisty E., Devers P., Kaiser-Rogers K., Hayden M.A., Goodnight W., Vora N.L. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat. Diagn. 2013, 33:609-611.
99. Vandenberghe P., Wlodarska I., Tousseyn T., et al. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study. Lancet Haematol. 2015, 2:55-65.
100. Amant F., Verheecke M., Wlodarska I., Dehaspe L., Brady P., Brison N., Van Den Bogaert K., Dierickx D., Vandecaveye V., Tousseyn T., Moerman P., Vanderstichele A., Vergote I., Neven P., Berteloot P., Putseys K., Danneels L., Vandenberghe P., Legius E., Vermeesch J.R. Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing. JAMA Oncol. 2015, 1:814-819.
101. Sistermans E.A., Straver R., Faas B. Letter to the editor: response to JAMA article noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA 2015, 314:2192-2193.
102. Curnow K.J., Wilkins-Haug L., Ryan A., Kirkizlar E., Stosic M., Hall M.P., Sigurjonsson S., Demko Z., Rabinowitz M., Gross S.J. Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test. Am. J. Obstet. Gynecol. 2015, 212:79.
103. Futch T., Spinosa J., Bhatt S., de Feo E., Rava R.P., Sehnert A.J. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat. Diagn. 2013, 33:569-574.
104. Scheffer P.G., van der Schoot C.E., Page-Christiaens G.C., Bossers B., van Erp E.F., de Haan H.M. Reliability of fetal sex determination using maternal plasma. Obstet. Gynecol. 2010, 115:117-126.
105. Akolekar R., Finning K., Kuppusamy R., Daniels G., Nicolaides K.H. Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation. Fetal Diagn. Ther. 2011, 29:301-306.
106. Hill M., Twiss P., Verhoef T., Drury S., McKay F., Mason S., Jenkins L., Morris S., Chitty L.S. Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis. Prenat. Diagn. 2015, 35:950-958.
107. van den Oever J.M., Bijlsma E.K., Feenstra I., Muntjewerff N., Mathijssen I.B., Bakker E., van Belzen M.J., Boon E.M. Noninvasive prenatal diagnosis of Huntington disease: detection of the paternally inherited expanded CAG repeat in maternal plasma. Prenat. Diagn. 2015, 35:945-949.
108. TRIDENT 2014, Trial by Dutch laboratories for Evaluation of Non-Invasive Prenatal Testing (NIPT), 2014 (15-6-2015).
109. Hill M., Wright D., Daley R., Lewis C., McKay F., Mason S., Lench N., Howarth A., Boustred C., Lo K., Plagnol V., Spencer K., Fisher J., Kroese M., Morris S., Chitty L. Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol. BMC Pregnancy Childbirth 2014, 14:229.
110. Gray J.A., Patnick J., Blanks R.G. Maximising benefit and minimising harm of screening. BMJ 2008, 336:480-483.
111. Benn P., Borell A., Chiu R., Cuckle H., Dugoff L., Faas B., Gross S., Johnson J., Maymon R., Norton M., Odibo A., Schielen P., Spencer K., Huang T., Wright D., Yaron Y. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat. Diagn. 2013, 33:622-629.
112. Devers P.L., Cronister A., Ormond K.E., Facio F., Brasington C.K., Flodman P. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. J. Genet. Couns. 2013, 22:291-295.
113. Sachs A., Blanchard L., Buchanan A., Bianchi D.W. Recommended pre-test counseling points for noninvasive prenatal testing using cell-free DNA: a 2015 perspective. Prenat. Diagn. 2015, 35:968-971.
114. NIPT/Cell Free DNA Screening Predictive Value Calculator 2015, http://www.perinatalquality.org/Vendors/NSGC/NIPT/.
115. Al-Aqeel A.I. Ethical guidelines in genetics and genomics. An Islamic perspective. Saudi Med. J. 2005, 26:1862-1870.
116. Chandrasekharan S., Minear M.A., Hung A., Allyse M. Noninvasive prenatal testing goes global. Sci. Transl. Med. 2014, 6:231fs15.
117. Hui L., Hyett J. Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia. Aust. N. Z. J. Obstet. Gynaecol. 2013, 53:416-424.
118. About the PEGASUS project. http://pegasus-pegase.ca/pegasus/2015.
119. Minear M.A., Lewis C., Pradhan S., Chandrasekharan S. Global perspectives on clinical adoption of NIPT. Prenat. Diagn. 2015, 35:959-967.
120. Wald N.J., Huttly W.J., Bestwick J.P., Aquilina J., Peregrine E. Reflex antenatal DNA screening for Down syndrome. Prenat. Diagn. 2015, 35:1154.
121. Wald N.J., Bestwick J.P. Performance of antenatal reflex DNA screening for Down's syndrome. J. Med. Screen. 2015, 22:168-174.
122. Dondorp W., de Wert G.M., Bombard Y., Bianchi D.W., Bergmann C., Borry P., Chitty L.S., Fellmann F., Forzano F., Hall A., Henneman L., Howard H.C., Lucassen A., Ormond K., Peterlin B., Radojkovic D., Rogowski W., Soller M., Tibben A., Tranebjarg L., van El C.G., Cornel M.C. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur. J. Hum. Genet. 2015, 23:1438-1450.
123. Warsof S.L., Larion S., Abuhamad A.Z. Overview of the impact of noninvasive prenatal testing on diagnostic procedures. Prenat. Diagn. 2015, 35:972-979.
124. Pettit K.E., Hull A.D., Korty L., Jones M.C., Pretorius D.H. The utilization of circulating cell-free fetal DNA testing and decrease in invasive diagnostic procedures: an institutional experience. J. Perinatol. 2014, 34:750-753.
125. Wax J.R., Cartin A., Chard R., Lucas F.L., Pinette M.G. Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection. J. Clin. Ultrasound 2015, 43:1-6.
126. Ames A.G., Metcalfe S.A., Dalton A.A., Duncan R.E., Emery J. Measuring informed choice in population-based reproductive genetic screening: a systematic review. Eur. J. Hum. Genet. 2015, 23:8-21.
127. Ekelund C.K., Jorgensen F.S., Petersen O.B., Sundberg K., Tabor A. Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study. BMJ 2008, 337:2547.
128. de Jong A., Dondorp W., Krumeich A., Boonekamp J., van Lith J., de Wert G.M. The scope of prenatal diagnosis for women at increased risk for aneuploidies: views and preferences of professionals and potential users. J. Community Genet. 2013, 4:125-135.
129. van Schendel R.V., Dondorp W.J., Timmermans D.R.M., van Hugte E.J.H., de Boer A., Pajkrt E., Lachmeijer A.M.A., Henneman L. NIPT-based screening for Down syndrome and beyond: what do pregnant women think?. Prenat. Diagn. 2015, 35:598-604.
130. van Schendel R.V., Kleinveld J.H., Dondorp W.J., Pajkrt E., Timmermans D.R.M., Holtkamp K.C.A., Karsten M., Vlietstra A.L., Lachmeijer A.M.A., Henneman L. Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening. Eur. J. Hum. Genet. 2014, 22:1345-1350.
131. Lewis C., Hill M., Silcock C., Daley R., Chitty L.S. Non-invasive prenatal testing for trisomy 21: a cross-sectional survey of service users' views and likely uptake. BJOG 2014, 121:582-594.
132. Tamminga S., van Schendel R.V., Rommers W., Bilardo C.M., Pajkrt E., Dondorp W.J., van Maarle M.C., Cornel M.C., Henneman L. Changing to NIPT as a first-tier screening test and future perspectives: opinions of health professionals. Prenat. Diagn. 2015, 35:1316-1323.
133. van den Heuvel A., Chitty L., Dormandy E., Newson A., Deans Z., Attwood S., Haynes S., Marteau T.M. Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals. Patient Educ. Couns. 2010, 78:24-28.
134. Allyse M.A., Sayres L.C., Havard M., King J.S., Greely H.T., Hudgins L., Taylor J., Norton M.E., Cho M.K., Magnus D., Ormond K.E. Best ethical practices for clinicians and laboratories in the provision of noninvasive prenatal testing. Prenat. Diagn. 2013, 33:656-661.
135. Kellogg G., Slattery L., Hudgins L., Ormond K. Attitudes of mothers of children with Down syndrome towards noninvasive prenatal testing. J. Genet. Couns. 2014, 23:805-813.
136. Munthe C. A new ethical landscape of prenatal testing: individualizing choice to serve autonomy and promote public health: a radical proposal. Bioethics 2015, 29:36-45.
137. Beulen L., Grutters J.P., Faas B.H., Feenstra I., van Vugt J.M., Bekker M.N. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2014, 182:53-61.
138. Benn P., Borrell A., Cuckle H., Dugoff L., Gross S., Johnson J.A., Maymon R., Odibo A., Schielen P., Spencer K., Wright D., Yaron Y. Prenatal detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. Prenat. Diagn. 2012, 32:1-2.
139. American College of Obstetricians and Gynecologists Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet. Gynecol. 2012, 120:1532-1534.
140. Morain S., Greene M.F., Mello M.M. A new era in noninvasive prenatal testing. N. Engl. J. Med. 2013, 369:499-501.
141. Committee Opinion No. 640: cell-free DNA screening for fetal aneuploidy, Obstet. Gynecol. (2015).
142. Oudejans C.B. Maternal plasma RNA sequencing. Clin. Biochem. 2015, 48:942-947.
143. Williams Z., Ben-Dov I.Z., Elias R., Mihailovic A., Brown M., Rosenwaks Z., Tuschl T. Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:4255-4260.
144. Koh W., Pan W., Gawad C., Fan H.C., Kerchner G.A., Wyss-Coray T., Blumenfeld Y.J., El-Sayed Y.Y., Quake S.R. Noninvasive in vivo monitoring of tissue-specific global gene expression in humans. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:7361-7366.
145. Zhang X.O., Wang H.B., Zhang Y., Lu X., Chen L.L., Yang L. Complementary sequence-mediated exon circularization. Cell 2014, 159:134-147.
146. Tsui N.B., Jiang P., Wong Y.F., Leung T.Y., Chan K.C., Chiu R.W., Sun H., Lo Y.M. Maternal plasma RNA sequencing for genome-wide transcriptomic profiling and identification of pregnancy-associated transcripts. Clin. Chem. 2014, 60:954-962.
147. Denis M.M., Tolley N.D., Bunting M., Schwertz H., Jiang H., Lindemann S., Yost C.C., Rubner F.J., Albertine K.H., Swoboda K.J., Fratto C.M., Tolley E., Kraiss L.W., McIntyre T.M., Zimmerman G.A., Weyrich A.S. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 2005, 122:379-391.
148. Nilsson R.J., Balaj L., Hulleman E., van R.S., Pegtel D.M., Walraven M., Widmark A., Gerritsen W.R., Verheul H.M., Vandertop W.P., Noske D.P., Skog J., Wurdinger T. Blood platelets contain tumor-derived RNA biomarkers. Blood 2011, 118:3680-3683.